APPLICATIONS PUBLISHED 17 NOVEMBER 2004

Published: 2-Jun-2005
Hair Care

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492

  • Topical ivermectin compsn
    Merck; McNeil-PPC 1476121*

  • Improvement of non-oxidative hair colouring using yogurt
    Quest International 1476122*

  • NSAID-containing topical formulations that demonstrate chemoprotective activity
    PharmaQest 1476127*

  • Lipase inhibiting compsn
    Procter & Gamble 1476128*

  • Compsns for skin whitening containing lyosophosphatidylethanolamine as an active ingredient
    Doosan Corp 1476129*

  • Preparations containing diol
    Beiersdorf 1476130*

  • Compsns and methods for delivery of skin cosmeceuticals
    Hydron Technologies 1476131*

  • Pharmaceutical compsn comprising N-((1-N-butyl-4-piperidinyl)-menthyl)-3,4-dihydro-2H-(1,3)oxazino(3,2,A)indole-10-carboxamide or salt and process therefore comprising dry granulation
    Glaxo Group 1476136*

  • Compsn comprising low water soluble compounds within porous carriers
    Phares Pharmaceutical Research 1476137*

  • Modified release formulations of at least one form of tramadol
    Biovail Laboratories 1476138*

  • Controlled release dosage forms
    Biovail Laboratories 1476139*

  • Taste-masked film-type or wafer-type medicinal preparation
    LTS Lohmann Therapie-Systeme 1476140*

  • Tamper-resistant transdermal opioid delivery devices
    Euro-Celtique 1476141*

  • Compsns for pulmonary administration
    Orion Corp 1476142*

  • Compsns comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
    DSM 1476143*

  • Synergistic mixtures of O-phenyl-phenol and other nitrogen and aldehyde microbicides
    Verichem 1476144*

  • Anti-nausea and anti-vomiting activity of cannabidiol compounds
    Yissum Research Development of the Hebrew University of Jerusalem 1476145*

  • Use for cyclo-oxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
    Pharmacia 1476146*

  • Methods for treating eye disorders
    Tatton Technologies 1476147*

  • Partial dopamine-D2 receptor agonist plus serotonin and/or noradrenaline inhibitor activity
    Solvay Pharmaceuticals 1476148*

  • Substituted hydrazones as inhibitors of cyclo-oxygenase-2
    Temple University of the Commonwealth System of Higher Education 1476149*

  • Carboxyfullerenes and methods of use thereof
    Washington University School of Medicine 1476150*

  • 1-arylsulphonyl-3-substituted indole and indoline derivatives useful in the treatment of central nervous system disorders
    Akzo Nobel 1476151*

  • Use of melatonin analogues for induction of general anaesthesia
    University of Iowa Research Foundation 1476152*

  • Method of treating and preventing bone loss
    F Hoffmann-La Roche 1476153*

  • Use of the inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
    Aventis Pharma Deutschland 1476154*

  • Methods and compsns for reducing the development of drug tolerance and/or physical dependence
    The Regents of the University of California 1476155*

  • Piperidine or pyrrolidine derivatives having an aminoacyl substituted side-chain as melanocortin-4 receptor agonists
    Chiron Corp 1476156*

  • Nicotinamide derivatives useful as PDE4 inhibitors
    Pfizer 1476157*

  • Nicotinamide derivatives useful as PDE4 inhibitors
    Pfizer 1476158*

  • Compsns and formulations of 9-nitrocamptothecin polymorphs and methods of use thereof
    SuperGen 1476159*

  • Pharmaceutical combination of artesunate and mefloquine for therapy of malaria
    Mepha 1476160*

  • Piperidine and pioperazine derivatives possessing affinity at 5HT-1 type receptors
    Glaxo 1476161*

  • Controlled synthesis of ziprasidone and compsns thereof
    Pfizer 1476162*

  • Method of treating HIV infection by preventing interaction of CD4 and GP120
    Bristol-Myers Squibb 1476163*

  • Quinoxalinones and their use especially in the treatment of cardiovascular diseases
    Bayer HealthCare 1476164*

  • Substituted pyrimidones and pyrimidinthiones
    Pharmacia & Upjohn 1476165*

  • Use of low molecular weight compounds useful for preparing a medicament useful in treating mutant P53 mediated diseases
    Aprea 1476166*

  • Use of acylaminoalkylene-amide derivatives in functional motility disorders of the viscera
    Novartis 1476167*

  • Use of co-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
    ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda 1476168*

  • Methods of inhibiting orthopoxvirus replication with nucleoside compounds
    Merck 1476169*

  • Method for curing cyanoacrylate adhesives
    Spartan Products 1476170*

  • Transportation of nucleic acid substances
    Pitmy International 1476171*

  • Use of biotechnological honey substitute in a cosmetic or dermatological compsn
    Societe d'Extraction des Principes Actifs (Vincience SA) 1476172*

  • Outer membrane vesicles from gram-negative bacteria and use as a vaccine
    Health Protection Agency 1476173*

  • Pharmaceutical compsn having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
    Wu, Tzu-Sheng 1476174*

  • Hedgehog-related prophylaxis, therapy and diagnosis of GI tract carcinogenesis
    Academisch Ziekenhuis bij de Universiteit van Amsterdam 1476175*

  • Transport peptides and uses therefore
    Yale University 1476176*

  • Peptide constructs for treating disease
    Cel-Sci Corp 1476177*

  • Formulation strategies in stabilising peptides in organic solvents and in dried states
    Bayer Pharmaceuticals 1476178*

  • Methods of preventing or treating brain ischaemia or brain injury
    Quark Biotech 1476179*

  • Interleukin-2 mutants with reduced toxicity
    University of Southern California 1476180*

  • Polyalkylene polymer compounds and uses thereof
    Biogen 1476181*

  • Immunogenic formulations of variable peptidic epitopes and process for preparations thereof
    Variation Biotechnologies 1476182*

  • An immunological adjuvant
    Lyflathroun HF Biotechnological Research 1476183*

  • Immunogen adherence and method of making and using the same
    Camas 1476184*

  • Antibodies to CD40
    Pfizer 1476185*

  • Use of an inhibitor or antagonist against tissue factor
    Prophy Med 1476186*

  • Methods of extending corneal graft survival
    Allergan 1476187*

  • Method for accessing microbial diversity
    Fraunhofer USA 1476188*

  • The use of TNF-alpha antagonist as drugs for the treatment of patients with sepsis and without suffering from total organ failure
    Abbott 1476189*

  • Amino-substituted hypcrellins for use as sonosensitisers
    Altachem Pharma 1476190*

  • Oral administration of interferon-tau
    Pepgen Corp 1476191*

  • Methods and compsns for treating hyperproliferative conditions
    Dana-Faerber Cancer Institute 1476192*

  • A weight management system for obese animals
    Mars 1476193*

  • Compsns and methods for preservation of food
    Eden Research 1476194*

  • Enhancement of the action of central and peripheral nervous system agents
    Pitmy International 1476195*

  • Oral solid solution formulation of a poorly water soluble substance
    Solvay Pharmaceuticals 1476196*

  • Synthesis of lipopolysaccharide-protein conjugate vaccines via the lipid A region following removal of the glycosidic phosphate residue
    National Research Institute of Canada 1476197*

  • Use of buckysome or carbon nanotube for drug delivery
    C Sixty 1476198*

  • Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds
    Research Development Foundation 1476199*

  • Compsns and method for regulation of calcium-dependent signalling in brain
    The Rockefeller University 1476200*

  • Solvent-based sterilisation of pharmaceuticals
    Resolution Chemicals 1476201*

  • Cross-linked bioactive hydrogel matrices
    Encelle 1476202*

  • Material for implantation
    La Jolla Bioengineering Institute 1476203*

  • Immobilised bioactive hydrogel matrices as surface coatings
    Encelle 1476204*

  • Implantable or insertable medical device resistant to microbial growth and biofilm formation
    Boston Scientific 1476205*

  • Compsns comprising undifferentiated fetal cells for the treatment of skin disorders
    Neocutis 1476206*

  • Novel amino acid derivatives, method for production thereof and pharmaceutical compsns comprising said derivative
    Les Laboratoires Servier 1476421*

  • Method for treating an imide organic solution bearing a sulphonyl group
    Rhodia Chimie 1476422*

  • Arylsulphonamidobenzylic compounds
    Tularik 1476423*

  • Ketone peroxide compsns
    Akzo Nobel 1476424*

  • Heterocyclic arylsulphonamidobenzylic compounds
    Tularik 1476425*

  • Hydroxylated indirubin derivatives
    Eisenbrand, Gerhard 1476426*

  • Peptide beta-strand mimics based on 1,2-dihydro-3(6H)-pyridinone
    The Regents of the University of California 1476427*

  • Pyridyl sulphone derivatives as 5-HT6 receptor ligands
    Pharmacia & Upjohn 1476428*

  • Novel pyridine- and quinoline-derivatives
    F Hoffmann-La Roche 1476429*

  • Method for the preparation of ethylenically unsaturated compounds with lactam-blocked isocyanate groups
    DSM 1476430*

  • Tricyclic pyrazole derivatives for the treatment of inflammation
    Pharmacia 1476431*

  • Therapeutic substituted indazole derivatives
    AstraZeneca 1476432*

  • Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments
    Pierre Fabre Medicament 1476433*

  • Pyridazine derivatives, use of the same as medicaments, pharmaceutical compsns and method for producing the same
    Aventis Pharma 1476434*

  • Novel pyridin- and pyrimidin-derivatives
    F Hoffmann-La Roche 1476435*

  • Method for producing 2-anilino-4,6-dimethylpyrimidine
    Degussa 1476436*

  • Novel tetrazole derivative useful as herbicides
    Bayer CropScience 1476437*

  • Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
    Vernalis (Oxford); Laboratoires Serono 1476438*

  • Preparation of N-methyl-3-hydroxy-3-(2-thienyl)propylamine via novel thiophene derivatives containing carbamate groups as intermediates
    Degussa 1476439*

  • Methods and compsns useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
    Albany College of Pharmacy 1476440*

  • A method of eliminating sulphone analogue in the synthesis of pyridine-benzimidazole sulphoxides
    Ulkar Kimya Sanayii Ve Tikaret 1476442*

  • Process for preparing indolinone derivatives
    Pharmacia & Upjohn 1476443*

  • Heterocyclic compounds possessing affinity at 5HT1-type receptors and use thereof in therapy
    Glaxo Group 1476444*

  • Tricyclic N-acyl compounds
    Altana Pharma 1476445*

  • Method for producing N-ethyl-N-3-(3-cyanopyrazolo 1,5A)pyrimidine acetamide
    Cilag 1476446*

  • Cyclic compounds and their use as complex ligands
    BASF 1476447*

  • Azabicyclic compounds for the treatment of disease
    Pharmacia & Upjohn 1476448*

  • Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
    Pharmacia & Upjohn 1476449*

  • Method of making N-2-aminoethylaminoalkylalkoxysilanes with ethylene diamine salt recycle
    Dow Corning 1476450*

  • Use of certain diluents for making bisphosphonic acids
    Teva Pharmaceutical Industries 1476451*

  • Acyl- and bisacylphosphine derivatives
    BASF 1476452*

  • Method for producing 6-alkoxy-(6H)-dibenz C,E] 1,2]-oxaphosphines
    Forschungszentrum Karlsruhe 1476453*

  • Binding epitopes for Helicobacter pylori and use thereof
    Biotie Therapies 1476454*

  • Partial and full agonists of a SB 1/SB adenosine receptors
    CV Therapeutics 1476455*

  • Compsns and methods for surrogate antibody modulation of an immune response and transport
    Syntherica Corp 1476456*

    See more

    • You may also like

    Ingredients

    Lubrizol acquires Nalco’s personal care business

    Read more
    Nalco to concentrate on core business

    Trending Articles

    1. APPLICATIONS PUBLISHED 17 NOVEMBER 2004 The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
    2. Lubrizol acquires Nalco’s personal care business Nalco to concentrate on core business

    Upcoming event

    EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

    16 January 2025 | Virtual     See all

    You may also like

    Ingredients

    Lubrizol acquires Nalco’s personal care business

    Nalco to concentrate on core business
    Subscribe now